Janux Therapeutics, Inc.JANXNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-59.51%
↑ 49% vs avg
Percentile
P33
Within normal range
Streak
2 yr
Consecutive declineDecelerating
Average
-116.55%
Historical baseline
PeriodValue
2025-59.51%
2024-35.45%
2023-8.78%
2022-103.74%
2021-579.93%
2020-28.43%
20190.00%